Vivo Infusion reaches 55 ASCs

Ambulatory infusion services provider Vivo Infusion has acquired Specialty Infusion, an industry leader with 14 ambulatory infusion centers in New York, New Jersey and Massachusetts. 

Advertisement

With the new acquisition, Vivo will now have 55 ambulatory infusion sites across 10 states, according to a June 20 press release. 

Specialty Infusion offers therapies across allergy/immunology, gastroenterology, neurology, and rheumatology.

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in ASC Transactions & Valuation Issues

Advertisement

Comments are closed.